Recent Posts
- HealthInvest June 2026: A Look Inside Australia's Healthcare Innovations16 Jun 2026
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences19 May 2026
- Lifesaving Capital: How impact investing is shaping the future of biotech30 Apr 2026
- Investor Relations: the quiet advantage powering ASX microcaps28 Nov 2025
- HealthInvest Sydney: Life Sciences in the Investor Spotlight06 Oct 2025
Archives

02 Apr 2018 · IR Department
Innovating sleep apnoea care
Sleep apnoea is a potentially serious condition but only one in five patients are in care. Oventus (ASX:OVN) is innovating sleep apnoea care with its patented airway design that creates a 'second…
Read article
07 Mar 2018 · IR Department
Getting the most from your roadshow
For more information or to contact us, please visit www.irdepartment.com.au.
Read article
05 Mar 2018 · IR Department
Why M&A is a major investment theme for 2018
"I'm told this is the three or four days of the whole year where most of the deals in biotech are done, and medical device companies," Paul says.
Read article
28 Feb 2018 · IR Department
New LinkedIn features you should care about
LinkedIn plays a pivotal role in our communication strategies because it’s the biggest B2B social marketing platform out there. Whether or not you should be using LinkedIn is a subject for another…
Read article
18 Feb 2018 · IR Department
How small caps can communicate better with investors: Three tips from an award-winning financial planner
Small caps need to do much more than just issue an ASX announcement at the right time to successfully communicate with investors. It takes a strategic approach and the right tools to build a loyal…
Read article
26 Sep 2017 · IR Department
3 key things an analyst looks at when researching a small company
Management is a far greater area of focus for analysts when assessing small companies due to resourcing, the phase of a company’s development and resulting ‘key man risk’.
Read article
07 Jun 2017 · IR Department
How useful is independent research? Heard of MiFID II?
MiFID, or Markets in Financial Instruments Directive, is the EU’s investor protection legislation. MiFID was applied in Europe in 2004 to regulate firms who provide services to clien...
Read article
26 May 2017 · IR Department
IR Department and DEC PR support Skyfii (ASX: SKF)
Skyfii's ‘IO’ subscription based Software as a Service (SaaS) platform turns data captured from multiple sources into actionable insights which help clients such as shopping centres, airports and ...
Read article
22 May 2017 · IR Department
AdAlta's Sam Cobb on the company's unique antibody platform
We're honoured to work with some companies that are doing some truly remarkable things. They’re creating products with the power to change lives, and even save lives in some cases. One such company ...
Read article
10 Mar 2017 · IR Department
Novogen's Dr James Garner explores the company's transformation
The former head of Sanofi's Research and Development team in Singapore, Dr Garner has very intentionally shifted Novogen's focus, business model and team. So much so that the company has in-licensed a...
Read article